SCHEMBL7717869

SCHEMBL7717869

Cc1cc(Oc2ccc(C(=O)OC(C)(C)C)cc2)ccc1N(CCO)CCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
ESRRA P11474 1/20 0.37
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
MMP13 P45452 1/20 0.35
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ELANE P08246 2/20 0.33
HPGD P15428 2/20 0.33
GFER P55789 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711926 0.89 ESRRA (0.36) ALDH1A1ESRRACA12CA1CA2
SCHEMBL8724206 0.80 MAPT (0.48) ALDH1A1LMNASMN1; SMN2HPGDKMT2A
SCHEMBL7711932 0.76 CA12 (0.43) ALDH1A1ESRRACA12CA1CA2
SCHEMBL5918245 0.76 HPGD (0.54) ALDH1A1ESRRACA12CA1CA2
SCHEMBL31063578 0.75 CA1 (0.42) ALDH1A1ESRRACA12CA1CA2
SCHEMBL7717390 0.73 MAPT (0.36) ALDH1A1CA12CA1CA9LMNA
SCHEMBL7711928 0.73 MCL1 (0.43) CA1CA2RARARARBRARG
SCHEMBL7717398 0.72 TSHR (0.50) ALDH1A1LMNASMN1; SMN2HPGDKMT2A
SCHEMBL31063581 0.71 TDP1 (0.43) ALDH1A1ESRRACA12CA1CA2
SCHEMBL21015888 0.71 HDAC4 (0.46) ALDH1A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436691-B1 CONJUGATE WHICH IS SUBSTANTIALLY NON-IMMUNOGENIC IN HUMANS COMPRISING TARGETING MOIETY CAPABLE OF BINDING WITH TUMOR ASSOCIATED ANTIGEN LINKED TO MUTATED FORM OF CARBOXYPEPTIDASE B ENZYME CAPABLE OF CONVERTING PRODRUG INTO ANTICANCER DRUG ZENECA LIMITED (GB) 2002-08-20 US disclosed
EP-0844885-A2 CHEMICAL COMPOUNDS ZENECA LIMITED (GB) 1998-06-03 EP disclosed
WO-1997007769-A2 CHEMICAL COMPOUNDS ZENECA LIMITED (GB) 1997-03-06 WO disclosed